IASIC Speaker Series Presents The Dangerous Truth About Today’s Marijuana: High-Potency, Psychosis, and Suicide

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed, organized, and guided by doctors.

 

Presented By: Libby Stuyt, MD and Laura Stack
Date: Tuesday, November 16, 2021
Time: 1:00PM Eastern/10:00AM Pacific
Price: FREE

Laura Stack’s 19-year-old son, Johnny, died by suicide on November 20, 2019, after becoming delusional from dabbing high-THC marijuana concentrates. Soon afterward, Laura started a 501c3, Johnny’s Ambassadors, to educate parents and teens about the dangers of today’s high-THC marijuana on adolescent brain development, mental illness, and suicide. In this session, Laura will share the story of Johnny’s marijuana addiction from a parent’s point of view.

Then Dr. Libby Stuyt will provide scientific-based research on the correlation between cannabis, psychosis, and suicide. Dr. Stuyt will include the evidence that high-potency concentrates, such as what Johnny was using, are the worst culprits, and how we have attempted to put some controls on these with legislation in Colorado.

Weekly sessions in the IASIC Speaker Series are free to join and the schedule is constantly expanding! For more information visit www.IASICeducation.org.

Register For This FREE Session
View Upcoming Speakers

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents  Cannabis and Mental Health

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Placebo Effect a Major Driver of Pain Reduction in Cannabis Trials

A strong placebo response may be largely responsible for the significant pain reduction observed in clinical trials of cannabis-based therapies, results of a new meta-analysis suggest. Investigators found that while the effect size of cannabinoids on pain intensity was significant, the placebo effect was about the same. “The data from the present meta-analysis, including 1459

Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005–2019

Since 2005, diagnoses of cannabis use disorder have increased substantially among VHA patients, as they have in the general population and other patient populations. Possible explanations warranting investigation include decreasing perception of risk, changing laws, increasing cannabis potency, stressors related to growing socioeconomic inequality, and use of cannabis to self-treat pain. Clinicians and the public

Cannabis legalization and cannabis-involved pregnancy hospitalizations in Colorado

The primary objective of this study was to evaluate the association between presence of recreational cannabis dispensaries and prevalence of cannabis-involved pregnancy hospitalizations in Colorado. This was a retrospective cohort study of pregnancy-related hospitalizations co-coded with cannabis diagnosis codes in the Colorado Hospital Association from January 1, 2011, through December 31, 2018 (recreational cannabis began

Scroll to Top